Business
CONMED makes surgical devices and equipment.
CONMED grew revenue, remained profitable, generated positive free cash flow at a 7.5% operating margin. Free cash flow declined while capital spending and stock compensation grew faster than revenue.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 5.2%OK
- Profitability — Net income declined 64.5% to $47.055M from $132.423MWatch
- Cash flow — Free cash flow declined 2.0% to $150.883M from $153.884MWatch
- Margins — Operating margin contracted 787 bps to 7.46%Watch
- Accounting — Free cash flow declined while capital spending and stock compensation grew faster than revenueNote
- Insiders — 0 purchases and 4 salesNote
Where the revenue comes from
Fiscal 2025, as CONMED Corp reports it. History and quarterly detail are in the app.
- General Surgery$800.1M
- Orthopedic Surgery$574.6M
Leadership changes
From CONMED Corp's own filings, the day they're filed.
- Celine Martin · directors · appointmenteff. 2026-07-01
- John E. Gallagher · President · appointmenteff. 2026-06-17
- Kimberly Lockwood · Director · appointmenteff. 2026-06-01
Latest filings
- 8-K · Company announcement2026-07-29
- 10-Q · Quarterly report2026-07-29
- 8-K · Company announcement2026-06-17
- 8-K · Company announcement2026-06-04
- 8-K · Company announcement2026-06-01
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about CONMED Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.